X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ORCHID PHARMA LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ORCHID PHARMA LTD J.B.CHEMICALS/
ORCHID PHARMA LTD
 
P/E (TTM) x 15.7 -0.7 - View Chart
P/BV x 2.5 0.5 505.2% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   ORCHID PHARMA LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ORCHID PHARMA LTD
Sep-13
J.B.CHEMICALS/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs318194 164.0%   
Low Rs20035 570.0%   
Sales per share (Unadj.) Rs148.0276.5 53.5%  
Earnings per share (Unadj.) Rs19.1-79.2 -24.1%  
Cash flow per share (Unadj.) Rs23.9-43.5 -55.1%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.953.9 239.1%  
Shares outstanding (eoy) m84.8270.45 120.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.70.4 422.3%   
Avg P/E ratio x13.6-1.4 -938.1%  
P/CF ratio (eoy) x10.8-2.6 -410.1%  
Price / Book Value ratio x2.02.1 94.5%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9518,067 272.1%   
No. of employees `0002.72.8 97.6%   
Total wages/salary Rs m1,8412,527 72.9%   
Avg. sales/employee Rs Th4,590.96,956.1 66.0%   
Avg. wages/employee Rs Th673.4902.5 74.6%   
Avg. net profit/employee Rs Th592.1-1,993.0 -29.7%   
INCOME DATA
Net Sales Rs m12,55119,477 64.4%  
Other income Rs m542407 133.0%   
Total revenues Rs m13,09319,884 65.8%   
Gross profit Rs m2,0551,103 186.4%  
Depreciation Rs m4122,519 16.4%   
Interest Rs m965,227 1.8%   
Profit before tax Rs m2,088-6,236 -33.5%   
Minority Interest Rs m020 -2.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m469-125 -374.7%   
Profit after tax Rs m1,619-5,580 -29.0%  
Gross profit margin %16.45.7 289.2%  
Effective tax rate %22.52.0 1,118.9%   
Net profit margin %12.9-28.7 -45.0%  
BALANCE SHEET DATA
Current assets Rs m7,77811,014 70.6%   
Current liabilities Rs m4,35832,060 13.6%   
Net working cap to sales %27.2-108.1 -25.2%  
Current ratio x1.80.3 519.5%  
Inventory Days Days5595 57.6%  
Debtors Days Days8034 238.5%  
Net fixed assets Rs m5,71329,440 19.4%   
Share capital Rs m170705 24.1%   
"Free" reserves Rs m10,5472,043 516.3%   
Net worth Rs m10,9373,800 287.8%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m15,57446,510 33.5%  
Interest coverage x22.8-0.2 -11,816.6%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.80.4 192.5%   
Return on assets %11.0-0.8 -1,448.4%  
Return on equity %14.8-146.9 -10.1%  
Return on capital %20.0-3.7 -534.6%  
Exports to sales %48.737.9 128.6%   
Imports to sales %7.122.6 31.3%   
Exports (fob) Rs m6,1157,378 82.9%   
Imports (cif) Rs m8894,406 20.2%   
Fx inflow Rs m6,1697,513 82.1%   
Fx outflow Rs m1,2855,649 22.8%   
Net fx Rs m4,8841,865 261.9%   
CASH FLOW
From Operations Rs m1,3971,682 83.1%  
From Investments Rs m-320-9,860 3.2%  
From Financial Activity Rs m-1,1966,644 -18.0%  
Net Cashflow Rs m-102-1,535 6.7%  

Share Holding

Indian Promoters % 55.4 32.3 171.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.6 73.7%  
FIIs % 3.9 3.3 118.2%  
ADR/GDR % 0.0 4.6 -  
Free float % 37.0 55.3 66.9%  
Shareholders   30,437 84,811 35.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 16, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS